CD160, CD160 molecule, 11126

N. diseases: 87; N. variants: 8
Disease: Corneal Neovascularization ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0085109
Disease: Corneal Neovascularization
Corneal Neovascularization 		0.010 Biomarker disease BEFREE The additive effects of anti-CD160 and bevacizumab in the CNV model suggest that these compounds could act via different pathways, opening new therapeutic pathways for cotargeted or combination therapies. 29860455 2018